Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | HTR1A | P08908 | 1/20 | 0.39 |
| ▸ | CLPP | Q16740 | 1/20 | 0.39 |
| ▸ | ACHE | P22303 | 3/20 | 0.38 |
| ▸ | MMP13 | P45452 | 1/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.37 |
| ▸ | FAAH | O00519 | 1/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30337155 | 0.88 | TACR1 (0.43) | KMT2AHTR1AACHETHRB | |
| SCHEMBL30336976 | 0.88 | KMT2A (0.55) | KMT2AHTR1ACLPPACHEPKM | |
| SCHEMBL30337208 | 0.87 | ENPP2 (0.43) | HTR1AACHETHRBLMNA | |
| SCHEMBL30337060 | 0.85 | KMT2A (0.49) | KMT2AHTR1ACLPPACHEMMP13 | |
| SCHEMBL30337305 | 0.82 | HTR1A (0.43) | KMT2AHTR1AACHEMMP13PKM | |
| SCHEMBL30337169 | 0.82 | HTR1A (0.48) | KMT2AHTR1ACLPPACHEFAAH | |
| SCHEMBL30337129 | 0.80 | KMT2A (0.46) | KMT2ACLPPACHEPKM | |
| SCHEMBL28980919 | 0.80 | KMT2A (0.46) | KMT2ACLPPACHEPKM | |
| SCHEMBL30337139 | 0.78 | MCHR1 (0.42) | KMT2AHTR1AACHEPKMLMNA | |
| SCHEMBL26092261 | 0.78 | KMT2A (0.41) | KMT2AHTR1AACHEPKMFAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115916206-A | Novel compound and pharmaceutical composition for preventing or treating resistant cancer comprising same | 治愈医药社株式会社 | 2023-04-04 | — | — | CN | disclosed |